L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway

Bin-rui Yang; Nan Yu; Yan-hui Deng; Pui Man Hoi; Bin Yang; Guang-yu Liu; Wei-hong Cong; Simon Ming-Yuen Lee

doi:10.1007/s11655-015-2165-7

Your Location：

Home >

Browse articles >

L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway

OriginalPaper | Updated：2021-08-27

- L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway
- L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway
- 中国结合医学杂志（英文版） 2015年21卷第5期页码：361-368
- Affiliations：
  
  1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao,China
  2. Laboratory of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Supported by the grants from the Science and Technology Development Fund, Macau SAR (No. 078/2005/A2) and the Science and Technology Plan of Beijing (No. Z141100002214011)
- DOI：10.1007/s11655-015-2165-7
  中图分类号：
- 纸质出版日期：2015，
  
  网络出版日期：2015-3-17，
Scan for full text
Yang, Br., Yu, N., Deng, Yh. et al. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway., Chin. J. Integr. Med. 21, 361–368 (2015). https://doi.org/10.1007/s11655-015-2165-7

Bin-rui Yang, Nan Yu, Yan-hui Deng, et al. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway[J]. Chinese Journal of Integrative Medicine, 2015,21(5):361-368.
Yang, Br., Yu, N., Deng, Yh. et al. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway., Chin. J. Integr. Med. 21, 361–368 (2015). https://doi.org/10.1007/s11655-015-2165-7 DOI：

Bin-rui Yang, Nan Yu, Yan-hui Deng, et al. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway[J]. Chinese Journal of Integrative Medicine, 2015,21(5):361-368. DOI： 10.1007/s11655-015-2165-7.

摘要

To investigate whether I-tetrahydropalmatine (I-THP)

an alkaloid mainly present in Corydalis family

could ameliorate early vascular inflammatory responses in atherosclerotic processes. Fluorescently labeled monocytes were co-incubated with human umbilical vein endothelial cells (HUVECs)

which were pretreated with I-THP and then simulated with tumor necrosis factor (TNF)-α in absence of I-THP to determine if I-THP could reduce thecytokine-induced adhesion of monocytes to HUVECs. Then I-THP were further studied the underlying mechanisms through observing the transcriptional and translational level of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and the nuclear translocation of nuclear factor (NF)-κ B in HUVECs. L-THP could block TNF-α-induced adhesion of monocytes to HUVECs and could significantly inhibited the expression of ICAM-1 and VCAM-1 on cell surface by 31% and 36% at 30 μ mol/L. L-THP pretreatment could also markedly reduce transcriptional and translational level of VCAM-1 as well as mildly reduce the total protein and mRNA expression levels of ICAM-1. Furthermore

I-THP attenuated TNF-α-stimulated NF-κ B nuclear translocation. These results provide evidences supporting that I-THP could be a promising compound in the prevention and treatment of the early vascular inflammatory reaction in atherosclerosis by inhibiting monocyte adhesion to vascular endothelial cell through downregulating ICAM-1 and VCAM-1 in vascular endothelial cell based on suppressing NF-κ B.

Abstract

To investigate whether I-tetrahydropalmatine (I-THP)

an alkaloid mainly present in Corydalis family

could ameliorate early vascular inflammatory responses in atherosclerotic processes. Fluorescently labeled monocytes were co-incubated with human umbilical vein endothelial cells (HUVECs)

关键词

I-tetrahydropalmatineatherosclerosiscell adhesion moleculestumor necrosis factor-αnuclear factor-κ B

Keywords

I-tetrahydropalmatineatherosclerosiscell adhesion moleculestumor necrosis factor-αnuclear factor-κ B

references

Iwata H, Nagai R. Novel immune signals and atherosclerosis. Curr Atheroscler Rep 2012;14:484–490.

WHO. World Health Organization. Cardiovascular diseases (CVDs). Available from: http: //www.who.int/mediacentre/ factsheets/fs317/en/. 2013.

Narverud I, Retterstol K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, et al. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review. Atherosclerosis 2014;235:299–309.

Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317–325.

Schulz C, Massberg S. Atherosclerosis-Multiple Pathways to Lesional Macrophages. Sci Transl Med 2014;6:239ps232.

Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425–434.

Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223–229.

Blann AD, McCollum CN. Circulating endothelial cell/ leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994;72:151–154.

Mulvihill NT, Foley JB, Crean P, Walsh M. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur Heart J 2002;23:1569–1574.

Ridker PM, Lüscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 2014;35:1782–1791.

Hu JY, Jin GZ. Arcuate nucleus of hypothalamus involved in analgesic action of l-THP. Acta Pharmacol Sin 2000;21:439–444.

Jin GZ, Zhu ZT, Fu Y. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 2002;23:4–7.

Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. L-tetrahydropalmatine ameliorates development of anxiety and depression-related symptoms induced by single prolonged stress in rats. Biomol Ther (Seoul) 2014;22:213–222.

Chu H, Jin G, Friedman E, Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol 2008;28:491–499.

Wang JB, Mantsch JR. l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction. Future Med Chem 2012;4:177–186.

Huang K, Dai GZ, Li XH, Fan Q, Cheng L, Feng YB, et al. Blocking L-calcium current by l-tetrahydropalmatine in single ventricular myocyte of guinea pigs. Acta Pharmacol Sin 1999;20:907–911.

Zeng Q, Zhu W, Cao L, Liu F. Effects of L-THP on Ca2+ overload of cultured rat cardiomyocytes during hypoxia and reoxygenation. J Tongji Med Univ 2000;20:294–296.

Yang G, Wang P, Tang Y, Jiang C, Wang D. Effects of L-tetrahydropalmatine on energy metabolism, endothelin-1 and NO during acute cerebral ischemia-reperfusion of rats. J Tongji Med Univ 1999;19:285–287.

Liu B, Yang G. Effects of l-tetrahydropalmatine on the expressions of bcl-2 and bax in rat after acute global cerebral ischemia and reperfusion. J Huazhong Univ Sci Technolog (Med Sci) 2004;24:445–448.

Han Y, Zhang W, Tang Y, Bai W, Yang F, Xie L, et al. I-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemiareperfusion injury in rats. PLoS One 2012;7:e38627.

Yang G, Jiang C, Tang Y, Wang P. Effects of l-tetrahydropalmatine on neuron apoptosis during acute cerebral ischemia-reperfusion of rats. J Tongji Med Univ 2000;20:106–108.

Liu YL, Yan LD, Zhou PL, Wu CF, Gong ZH. Levotetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats. Eur J Pharmacol 2009;602:321–327.

Wu L, Ling H, Li L, Jiang L, He M. Beneficial effects of the extract from Corydalis yanhusuo in rats with heart failure following myocardial infarction. J Pharm Pharmacol 2007;59:695–701.

Zhang ZM, Jiang B, Zheng XX. Effect of l-tetrahydropalmatine on expression of adhesion molecules induced by lipopolysaccharides in human umbilical vein endothelium cell. China J Chin Mater Med (Chin) 2005;30:861–864.

Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533–537.

Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, et al. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol 1996;50:149–159.

Pradet-Balade B, Boulmé F, Beug H, Müllner EW, Garcia-Sanz JA. Translation control: bridging the gap between genomics and proteomics? Trends Biochem Sci 2001;26:225–229.

Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584–589.

Shephard RJ. Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise. Sports Med 2003;33:261–284.

Shingu M, Hashimoto M, Ezaki I, Nobunaga M. Effect of cytokine-induced soluble ICAM-1 from human synovial cells on synovial cell-lymphocyte adhesion. Clin Exp Immunol 1994;98:46–51.

Cybulsky MI, Gimbrone M. Endothelial Cell Dysfunction. In Simionescu N and Simionescu M, eds. New York: Plenum Press; 1992:129–140.

Baeuerle PA. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 1998;95:729–731.

Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992;267:16323–16329.

Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992;176:1583–1593.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effects of Wenxiao Decoction (稳消方) on the expression of interleukin-6, intercellular adhesion molecular-1 and monocyte chemoattractant protein-1 in experimental atherosclerotic rabbits

Effects of Modified Sanhuang Decoction (加味三黄汤) enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats

Inhibitory effect of cryptotanshinone on angiogenesis and Wnt/β-catenin signaling pathway in human umbilical vein endothelial cells

Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: Potential role in anti-atherosclerotic activity

Effects of Shenshao Decoction(参芍汤) on the inflammatory response in the aorta of a rat atherosclerotic model